Status:

TERMINATED

Comparing Immune Responses to Topical Imiquimod

Lead Sponsor:

University of California, Davis

Conditions:

Actinic Keratoses

Eligibility:

All Genders

18-85 years

Brief Summary

The study is a basic science research study that is designed to characterize and compare the immune response in individuals who are designated as ABO blood group secretors, meaning they have a functio...

Eligibility Criteria

Inclusion

  • Individuals between 18 to 85 years of age
  • Patients with a diagnosis that will result in treatment with imiquimod as standard of care, specifically actinic keratosis

Exclusion

  • Younger than 18 years or older than 85 years.
  • History of hypersensitivity/ allergic reaction or adverse reaction to imiquimod
  • Individuals with a diagnostic biopsy and supportive histology of a cutaneous immune-mediated disease (e.g. psoriasis and mycosis fungoides, etc.) or diseases of the hematopoietic system, liver and the gastrointestinal tract (e.g. aplastic anemia, Crohn's disease, Ulcerative Colitis, Primary Sclerosing Cholangitis (PSC), Primary Biliary Cirrhosis, acute and chronic graft versus host disease (GVHD)).
  • Individuals with autoantibodies plus objective evidence of end organ damage related to a cutaneous immune-mediated disease (e.g. psoriasis and mycosis fungoides, etc.) or diseases of the hematopoietic system, liver and the gastrointestinal tract (e.g. aplastic anemia, Crohn's disease, Ulcerative Colitis, Primary Sclerosing Cholangitis (PSC), Primary Biliary Cirrhosis, acute and chronic graft versus host disease (GVHD)).
  • Individuals with a history of serious infection within the last 6 months.
  • Individuals with tuberculosis, HIV, or hepatitis B, or C.
  • Patients unable to provide consent
  • Incarcerated individuals

Key Trial Info

Start Date :

March 16 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 7 2023

Estimated Enrollment :

6 Patients enrolled

Trial Details

Trial ID

NCT04809662

Start Date

March 16 2021

End Date

November 7 2023

Last Update

November 7 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California Davis

Sacramento, California, United States, 95816

Comparing Immune Responses to Topical Imiquimod | DecenTrialz